drugset / Trial / NCT00178048

Paroxetine in the Treatment of Chronic Primary Insomnia

NCT00178048

Phase 4 Completed 66 enrolled University of Pittsburgh GlaxoSmithKline · collab
RandomizedFactorialDouble-blindTreatment

Summary

The goal of the study is to examine the role of paroxetine, an antidepressant medication, in the acute and continuation treatment of insomnia. Primary insomnia is a type of insomnia not directly resulting from general medical, chemical, or psychiatric conditions.

Timeline

Start
1998-09
Primary completion
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule